Seema Dawood: Abnormal Nuclear Morphology of Neutrophil
Seema Dawood, Medical Laboratory Technologist at The Aga Khan University Hospital, shared a post on LinkedIn:
“Abnormal Nuclear Morphology of Neutrophil
Hyposegmented neutrophils
Neutrophils with nuclei having only 1–2 lobes or appear unsegmented
Unsegmented nucleus:
- Round or oval nucleus with no segmentation
- Bilobed nucleus: Two-lobed nucleus, often resembling pince-nez glasses
Commonly found in:
- Pelger-Huët Anomaly (PHA) – Congenital
- Pseudo PelgerHuët Anomaly (PPHA) – Acquired (associated with bone marrow disorders , severe infections , drug-induced or certain types of leukemia)
Hypersegmented neutrophils
Neutrophils with nuclei having more than 5 lobes (especially more than 6).
The nuclear segmentation is excessive but orderly.
Commonly seen in:
- Megaloblastic Anemia (e.g., Vitamin B12 or Folate deficiency)
- Myelodysplastic Syndromes
- Chemotherapy induced bone marrow suppression
Botryoid neutrophils
Neutrophils with multiple nuclear lobes arranged in a radial pattern, often connected by interchromatin bridges.
The nuclei resemble a ‘grape-like cluster’ (botryoid means grape-like).
Commonly observed in:
- Hyperthermia
- Heatstroke
- Severe bacterial infections
- Extensive burns
- Severe inflammatory responses
- Uremia (kidney failure)
- Chemotherapy or drug toxicity
- May also be observed in hematologic malignancies such as leukemia or myelodysplastic syndrome (MDS)
The presence of Botryoid Neutrophils is considered a warning sign that ‘the body is experiencing a serious pathological condition or critical systemic stress, particularly involving the immune system, severe infections, toxic states, or hematologic disorders.'”

See more in the gallery.
Other posts featuring Seema Dawood on Hemostasis Today.
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026